Impact of obesity on diagnosis and treatment of breast cancer

Breast Cancer Research and Treatment

Volumn 120, Issue 1, 2010, Pages 185-193

  Deglise, Carole ^a   Bouchardy, Christine ^a   Burri, Mafalda ^a   Usel, Massimo ^a   Neyroud Caspar, Isabelle ^a   Vlastos, Georges ^b   Chappuis, Pierre Olivier ^b   Ceschi, Michela ^d   Ess, Silvia ^e   Castiglione, Monica ^a   Rapiti, Elisabetta ^a   Verkooijen, Helena Marieke ^a,c  

^a GENEVA CANCER REGISTRY   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e St Gallen Cancer Registry ^*  (Switzerland)

Author keywords

Breast cancer; Diagnosis; Obesity; Population based; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; RECOMBINANT HORMONE; TRASTUZUMAB;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; ECHOGRAPHY; ECHOMAMMOGRAPHY; FEMALE; HOSPITALIZATION; HUMAN; INFANT; LEAN BODY WEIGHT; LENGTH OF STAY; LYMPH NODE; MAJOR CLINICAL STUDY; MASTECTOMY; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; SWITZERLAND; TUMOR VOLUME; UNDERWEIGHT;

AGED; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; LENGTH OF STAY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; OBESITY;

EID: 74849121680     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0459-1     Document Type: Article

References (50)

1. GK Reeves K Pirie V Beral J Green E Spencer 2007 Bull D cancer incidence and mortality in relation to body mass index in the million women study: cohort study BMJ 335 7630 1134 10.1136/bmj.39367.495995.AE 17986716 (Pubitemid 350247286)
2. PH Lahmann K Hoffmann N Allen CH Van Gils KT Khaw B Tehard F Berrino A Tjonneland J Bigaard A Olsen K Overvad F Clavel-Chapelon G Nagel H Boeing D Trichopoulos G Economou G Bellos D Palli R Tumino S Panico 2004 Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC) Int J Cancer 111 5 762 771 10.1002/ijc.20315 1:CAS:528:DC%2BD2cXmvVenu7w%3D 15252848 (Pubitemid 39062901)
3. C Bouchardy MG Le C Hill 1990 Risk factors for breast cancer according to age at diagnosis in a French case-control study J Clin Epidemiol 43 3 267 275 10.1016/0895-4356(90)90007-C 1:STN:280:DyaK3c7ovVCnsQ%3D%3D 2313317 (Pubitemid 20074211)
4. S Loi RL Milne ML Friedlander MR McCredie GG Giles JL Hopper KA Phillips 2005 Obesity and outcomes in premenopausal and postmenopausal breast cancer Cancer Epidemiol Biomarkers Prev 14 7 1686 1691 10.1158/1055-9965.EPI-05-0042 16030102 (Pubitemid 40995080)
5. JK Litton AM Gonzalez-Angulo CL Warneke AU Buzdar SW Kau M Bondy S Mahabir GN Hortobagyi AM Brewster 2008 Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer J Clin Oncol 26 25 4072 4077 10.1200/JCO.2007.14.4527 18757321
6. AR Carmichael T Bates 2004 Obesity and breast cancer: a review of the literature Breast 13 2 85 92 10.1016/j.breast.2003.03.001 1:STN:280: DC%2BD2c7islOgsw%3D%3D 15019686 (Pubitemid 38443602)
7. B Majed T Moreau K Senouci RJ Salmon A Fourquet B Asselain 2008 Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat 111 2 329 342 10.1007/s10549-007-9785-3 17939036
8. AR Carmichael 2006 Obesity as a risk factor for development and poor prognosis of breast cancer BJOG 113 10 1160 1166 10.1111/j.1471-0528.2006.01021. x 1:STN:280:DC%2BD28rkslOiug%3D%3D 16945118 (Pubitemid 44401209)
9. SM Enger JM Greif J Polikoff M Press 2004 Body weight correlates with mortality in early-stage breast cancer Arch Surg 139 9 954 958 10.1001/archsurg.139.9.954 15381612 (Pubitemid 39186744)
10. Bouchardy C, Geneva, Switzerland (2003) Cancer incidence in five continents. In: Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds) International agency for research on cancer, vol VIII. IARC, Lyon, pp 448-449
11. World Health Organization (WHO) (2008) WHO, global database on body mass index, BMI classification. 30-4-2008
12. Sobin LH, Ch Wittekind (eds) (2002) TNM classification of malignant tumours. UICC, New York
13. ICD-O International classification of diseases for oncology (1975) World Health Organization, Genève
14. Breslow NE, Day NE (1987) Statistical methods in cancer research: the design and analysis of cohort studies, vol II. International Agency for Research on Cancer, IARC Scientific Publications no 82, Lyon
15. GA Porter KM Inglis LA Wood PJ Veugelers 2006 Effect of obesity on presentation of breast cancer Ann Surg Oncol 13 3 327 332 10.1245/ASO.2006.03. 049 16485153 (Pubitemid 43255915)
16. YA Kim CW Lee 2004 Effects of obesity on breast cancer stage at diagnosis in Korean women Eur J Cancer Prev 13 1 13 17 10.1097/00008469-200402000-00003 1:STN:280:DC%2BD2c7otFOisg%3D%3D 15075783 (Pubitemid 38328114)
17. Y Cui MK Whiteman JA Flaws P Langenberg KH Tkaczuk TL Bush 2002 Body mass and stage of breast cancer at diagnosis Int J Cancer 98 2 279 283 10.1002/ijc.10209 1:CAS:528:DC%2BD38XhsVSkurY%3D 11857420 (Pubitemid 34150814)
18. KM Hahn ML Bondy M Selvan MJ Lund JM Liff EW Flagg LA Brinton P Porter JW Eley RJ Coates 2007 Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer Am J Epidemiol 166 9 1035 1044 10.1093/aje/kwm177 17690220 (Pubitemid 47574681)
19. Y Cui MK Whiteman P Langenberg M Sexton KH Tkaczuk JA Flaws TL Bush 2002 Can obesity explain the racial difference in stage of breast cancer at diagnosis between black and white women? J Womens Health Gend Based Med 11 6 527 536 10.1089/152460902760277886 12225626 (Pubitemid 34960150)
20. L Vona-Davis M Howard-McNatt DP Rose 2007 Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer Obes Rev 8 5 395 408 10.1111/j.1467-789X.2007.00396.x 1:STN:280:DC%2BD2svpslCqug%3D%3D 17716297 (Pubitemid 47283945)
21. R Verreault J Brisson L Deschenes F Naud 1989 Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors Am J Epidemiol 129 2 260 268 1:STN:280:DyaL1M7gtlalug%3D%3D 2912039
22. BO Maehle S Tretli 1996 Pre-morbid body-mass-index in breast cancer: reversed effect on survival in hormone receptor negative patients Breast Cancer Res Treat 41 2 123 130 10.1007/BF01807157 1:STN:280:DyaK2s%2FpvFOlsw%3D%3D 8944330 (Pubitemid 26360141)
23. R Suzuki T Rylander-Rudqvist W Ye S Saji A Wolk 2006 Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: a prospective cohort study Int J Cancer 119 7 1683 1689 10.1002/ijc.22034 1:CAS:528:DC%2BD28Xos1Khurw%3D 16646051 (Pubitemid 44258777)
24. GA Colditz BA Rosner WY Chen MD Holmes SE Hankinson 2004 Risk factors for breast cancer according to estrogen and progesterone receptor status J Natl Cancer Inst 96 3 218 228 1:CAS:528:DC%2BD2cXhtVKkurg%3D 14759989
25. JD Potter JR Cerhan TA Sellers PG McGovern C Drinkard LR Kushi AR Folsom 1995 Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 4 4 319 326 1:STN:280:DyaK2MzosVSjug%3D%3D 7655325
26. CI Li KE Malone JR Daling 2006 Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States) Cancer Causes Control 17 5 695 703 10.1007/s10552-005-0001-7 16633917 (Pubitemid 43668328)
27. K Yoo K Tajima S Park D Kang S Kim K Hirose T Takeuchi S Miura 2001 Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan) Cancer Lett 167 1 57 63 10.1016/S0304-3835(01)00463-3 1:CAS:528:DC%2BD3MXivFeiurs%3D 11323099 (Pubitemid 32373269)
28. H Honda Y Ohi Y Umekita T Takasaki K Kuriwaki I Ohyabu T Yoshioka A Yoshida S Taguchi K Ninomiya S Akiba S Nomura Y Sagara H Yoshida 1999 Obesity affects expression of progesterone receptors and node metastasis of mammary carcinomas in postmenopausal women without a family history Pathol Int 49 3 198 202 10.1046/j.1440-1827.1999.00846.x 1:CAS:528:DyaK1MXjtF2rsrw%3D 10338073 (Pubitemid 29210545)
29. MD Althuis JH Fergenbaum M Garcia-Closas LA Brinton MP Madigan ME Sherman 2004 Etiology of hormone receptor-defined breast cancer: A systematic review of the literature Cancer Epidemiol Biomarkers Prev 13 10 1558 1568 1:CAS:528:DC%2BD2cXotFWgu7w%3D 15466970
30. KB Horwitz WL Mcguire 1978 Estrogen control of progesterone receptor in human breast-cancer-correlation with nuclear processing of estrogen-receptor J Biol Chem 253 7 2223 2228 1:CAS:528:DyaE1cXhvVOlurc%3D 632265
31. L Vona-Davis DP Rose 2007 Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression Endocr Relat Cancer 14 2 189 206 10.1677/ERC-06-0068 1:CAS:528:DC%2BD2sXhtV2lsr%2FE 17639037 (Pubitemid 47242622)
32. AR Carmichael 2006 Obesity and prognosis of breast cancer Obes Rev 7 4 333 340 10.1111/j.1467-789X.2006.00261.x 1:STN:280:DC%2BD28ngs1KrtA%3D%3D 17038127 (Pubitemid 44564304)
33. BM Wolpin JA Meyerhardt AT Chan K Ng JA Chan K Wu MN Pollak EL Giovannucci CS Fuchs 2009 Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer J Clin Oncol 27 2 176 185 10.1200/JCO.2008.17.9945 19064975
34. MD Holmes WY Chen D Feskanich CH Kroenke GA Colditz 2005 Physical activity and survival after breast cancer diagnosis JAMA 293 20 2479 2486 10.1001/jama.293.20.2479 1:CAS:528:DC%2BD2MXksFWksbk%3D 15914748 (Pubitemid 40705729)
35. MJ Reeves PA Newcomb PL Remington PM Marcus WR MacKenzie 1996 Body mass and breast cancer. Relationship between method of detection and stage of disease Cancer 77 2 301 307 10.1002/(SICI)1097-0142(19960115)77:2<301::AID- CNCR12>3.0.CO;2-5 1:STN:280:DyaK283itleltQ%3D%3D 8625238 (Pubitemid 26023349)
36. HI Hall RJ Coates RJ Uhler LA Brinton MD Gammon D Brogan N Potischman KE Malone CA Swanson 1999 Stage of breast cancer in relation to body mass index and bra cup size Int J Cancer 82 1 23 27 10.1002/(SICI)1097-0215(19990702)82: 1<23::AID-IJC5>3.0.CO;2-E 1:STN:280:DyaK1M3oslGlsg%3D%3D 10360815 (Pubitemid 29266101)
37. AL Hoe MA Mullee GT Royle PB Guyer I Taylor 1993 Breast size and prognosis in early breast cancer Ann R Coll Surg Engl 75 1 18 22 1:STN:280:DyaK3s7jsFCqtA%3D%3D 8422138 (Pubitemid 23025891)
38. JM Ferrante PH Chen BF Crabtree D Wartenberg 2007 Cancer screening in women: body mass index and adherence to physician recommendations Am J Prev Med 32 6 525 531 10.1016/j.amepre.2007.02.004 17533069 (Pubitemid 46805196)
39. SS Cohen LB Signorello MD Gammon WJ Blot 2007 Obesity and recent mammography use among black and white women in the Southern Community Cohort Study (United States) Cancer Causes Control 18 7 765 773 10.1007/s10552-007- 9019-3 17569015 (Pubitemid 46988244)
40. KR Fontaine M Heo DB Allison 2001 Body weight and cancer screening among women J Womens Health Gend Based Med 10 5 463 470 10.1089/152460901300233939 1:STN:280:DC%2BD3MzptFWgtQ%3D%3D 11445045 (Pubitemid 32677645)
41. CC Wee EP McCarthy RB Davis RS Phillips 2000 Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? Ann Intern Med 132 9 697 704 1:STN:280:DC%2BD3c3js12rsg%3D%3D 10787362
42. V Arndt T Sturmer C Stegmaier H Ziegler G Dhom H Brenner 2002 Patient delay and stage of diagnosis among breast cancer patients in Germany-a population based study Br J Cancer 86 7 1034 1040 10.1038/sj.bjc.6600209 1:STN:280:DC%2BD383hs1Kgsw%3D%3D 11953844
43. TA Wadden DA Anderson GD Foster A Bennett C Steinberg DB Sarwer 2000 Obese women's perceptions of their physicians' weight management attitudes and practices Arch Fam Med 9 9 854 860 10.1001/archfami.9.9.854 1:STN:280: DC%2BD3M%2FisVantw%3D%3D 11031392
44. MB El Tamer BM Ward T Schifftner L Neumayer S Khuri W Henderson 2007 Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care Ann Surg 245 5 665 671 10.1097/01.sla. 0000245833.48399.9a 17457156 (Pubitemid 46684093)
45. P Forouhi JM Dixon RC Leonard U Chetty 1995 Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancer Br J Surg 82 1 79 82 10.1002/bjs.1800820127 1:STN:280:DyaK2M7oslOluw%3D%3D 7881965
46. AM Munhoz E Montag EG Arruda C Aldrighi R Gemperli JM Aldrighi MC Ferreira 2006 Critical analysis of reduction mammaplasty techniques in combination with conservative breast surgery for early breast cancer treatment Plast Reconstr Surg 117 4 1091 1103 10.1097/01.prs.0000202121.84583.0d 1:CAS:528:DC%2BD2sXlvFCisw%3D%3D 16582770 (Pubitemid 44317793)
47. D Vilar-Compte B Jacquemin C Robles-Vidal P Volkow 2004 Surgical site infections in breast surgery: case-control study World J Surg 28 3 242 246 10.1007/s00268-003-7193-3 14961196 (Pubitemid 38375522)
48. DS Buist L Ichikawa MN Prout MU Yood TS Field C Owusu AM Geiger VP Quinn F Wei RA Silliman 2007 Receipt of appropriate primary breast cancer therapy and adjuvant therapy are not associated with obesity in older women with access to health care J Clin Oncol 25 23 3428 3436 10.1200/JCO.2007.11.4918 17687148 (Pubitemid 47310879)
49. JJ Griggs E Culakova ME Sorbero M van Ryn MS Poniewierski DA Wolff J Crawford DC Dale GH Lyman 2007 Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy J Clin Oncol 25 3 277 284 10.1200/JCO.2006.08.3063 17159190 (Pubitemid 350010638)
50. JJ Griggs ME Sorbero GH Lyman 2005 Undertreatment of obese women receiving breast cancer chemotherapy Arch Intern Med 165 11 1267 1273 10.1001/archinte.165.11.1267 15956006 (Pubitemid 40989591)